Loading insider details...
Beta
Latest Form 4 (Mar 3, 2026): Exercise/Conversion of 2,375 ACRS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 3, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 2,375 | n/a |
| Feb 6, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Grant/Award | 99,100 | n/a |
| Feb 5, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 22,025 | n/a |
| Feb 3, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 14,750 | n/a |
| Jan 5, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 73,750 | n/a |
| Mar 4, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 1,100 | n/a |
| Feb 4, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 14,750 | n/a |
| Jan 3, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 73,750 | n/a |
| Sep 4, 2024 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 1,000 | n/a |
| Mar 5, 2024 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 1,100 | n/a |